menu search

EPWCF / Empower Clinics announces proposed private placement, amendment of warrant terms and debt settlement

Empower Clinics announces proposed private placement, amendment of warrant terms and debt settlement
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced its intention to complete a non-brokered private placement of secured convertible debenture units at a price of $1,000 per unit, for aggregate gross proceeds of $250,000, and of common share units at a price of $0.05 each for aggregate gross proceeds of $1,000,000, or such other amount as may be determined by the company. The proceeds of the financing are expected to be used for working capital purposes and general administrative expenses. Read More
Posted: Nov 22 2022, 06:51
Author Name: Proactive Investors
Views: 111592

EPWCF News  

Empower Clinics signs letter of intent for equity capital facility

By Proactive Investors
June 6, 2023

Empower Clinics signs letter of intent for equity capital facility

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has signed a letter of intent (LOI) with Crescita Capital LLC for a C$5 million equity capital f more_horizontal

Empower Clinics looks to expand research opportunities, utilize financial advisor to grow shareholder value

By Proactive Investors
May 9, 2023

Empower Clinics looks to expand research opportunities, utilize financial advisor to grow shareholder value

Empower Clnincs Inc. has released a corporate update covering its developing research and clinical trials divisions.  Last month, Empower subsidiary more_horizontal

Empower Clinics signs fourth principal investigator for Dallas site

By Proactive Investors
May 3, 2023

Empower Clinics signs fourth principal investigator for Dallas site

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) announced that it has signed another agreement for a principal investigator (PI) at its research and clini more_horizontal

Empower Clinics adds two new researchers to support clinical trials services at its site in Dallas

By Proactive Investors
April 25, 2023

Empower Clinics adds two new researchers to support clinical trials services at its site in Dallas

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said its subsidiary, EPW Curesearch LLC, has signed two new research services agreements with leading phys more_horizontal

Empower Clinics signs clinical trials services deal with Texas medical group

By Proactive Investors
April 17, 2023

Empower Clinics signs clinical trials services deal with Texas medical group

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced an agreement to develop a program for research and clinical trials services with a Dallas, T more_horizontal

Empower Clinics commences process to explore and evaluate strategic options

By Proactive Investors
March 21, 2023

Empower Clinics commences process to explore and evaluate strategic options

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) said it has commenced a process to explore and evaluate strategic options to enhance and preserve shareho more_horizontal

Empower Clinics advances partnership to launch US clinical trial management services

By Proactive Investors
March 7, 2023

Empower Clinics advances partnership to launch US clinical trial management services

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has said its previously announced LOI (letter of intent) to create and operate a Dallas-based Site Manage more_horizontal

Empower Clinics ends Q4 2022 with $193,144 in cash; continues to focus on clinical trial services

By Proactive Investors
March 1, 2023

Empower Clinics ends Q4 2022 with $193,144 in cash; continues to focus on clinical trial services

Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has said it held $193,144 in cash at end-2022 as it announced its interim results for the fourth quarter t more_horizontal


Search within

Pages Search Results: